CAS 1143020-91-0

AZ-GHS-22

CAS: 1143020-91-0

AZ-GHS-22 is an investigational drug that has been shown to be effective in treating lung cancer. This drug inhibits the proliferation of tumor cells by inhibiting the cyclin-dependent kinase 2 (CDK2) and inducing cell apoptosis. AZ-GHS-22 also blocks the activation of pro-apoptotic protein and reduces bowel inflammation, which may be caused by its anti-inflammatory properties. The combination therapy group showed a better response to treatment than the monotherapy group. However, AZ-GHS-22 may have adverse effects on patients with infectious diseases or bowel disorders due to its ability to inhibit the synthesis of pro-apoptotic proteins.

Fórmula: C₂₈H₃₃N₇O₂

Pureza: Min. 95%

Peso molecular: 499.6 g/mol

Ref: 3D-TVB02091

AZ-GHS-22

CAS: 1143020-91-0

AZ-GHS-22, an inverse agonist for GHS-R1a (ghrelin receptor), binds with 0.77 nM IC50, cutting mice food intake by 54% at 100 mg/kg.

Fórmula: C₂₇H₃₃ClN₆O₅S₂

Forma y color: Solid

Peso molecular: 621.17

Ref: TM-T37412